Quality UGI Endoscopy in Australia & Aotearoa New Zealand
An interactive guide to the GESA, RACS, RACP & EGGNZ joint position statement. This tool translates the 40 key recommendations into an easily explorable format to support clinical best practice.
7-Minute Minimum
Recommended minimum procedure time for a routine diagnostic UGI endoscopy to improve lesion detection.
Photo Documentation
Systematic photo documentation of 8 key anatomical landmarks is a core quality indicator.
<10% Missed Cancer Rate
Target for post-endoscopy UGI cancer rate, audited every 3 years to ensure quality and safety.
Breakdown of Recommendations
The 40 recommendations are structured across the procedural workflow. Click a segment to explore the detailed guidelines for that phase.
Pre-Procedural Recommendations
This section outlines the five essential steps to complete before commencing a UGI endoscopy. These recommendations focus on ensuring procedural appropriateness, patient safety, and informed consent, forming the foundation for a high-quality examination.
Intra-Procedural Recommendations
This section details the eight core recommendations for conduct during the UGI endoscopy. The guidelines cover endoscopist competency, equipment standards, examination completeness, visualization techniques, procedure duration, and standardized reporting to maximize diagnostic yield and ensure a thorough, high-quality procedure.
The 7-Minute Impact
Studies show a longer procedure time significantly increases the detection of high-risk and neoplastic lesions. A minimum of 7 minutes is recommended for routine examinations.
Post-Procedural Recommendations
This section covers the five key recommendations for actions after the UGI endoscopy is complete. These steps are critical for ensuring patient safety during recovery, clear communication of findings, robust follow-up of histology, and continuous quality improvement through auditing.
Auditing Post-Endoscopy UGI Cancer (PEUGIC)
PEUGIC is a critical quality indicator, defined as cancer diagnosed 6-36 months after a negative endoscopy. The target rate is less than 10%.
A root cause analysis is recommended for all identified cases.
Disease-Specific Recommendations
The position statement provides 22 detailed recommendations for common and premalignant conditions. This section allows you to quickly access specific protocols for biopsy, classification, and management. Use the filters to find the condition you are interested in.
Endoscopy Surveillance Schedule for Barrett's Oesophagus
This tool guides you through the management recommendations for columnar-lined oesophagus (CLO) based on biopsy findings.
Post-Endoscopic Eradication Therapy (EET) Surveillance
Following successful EET for BO-associated neoplasia, follow these surveillance guidelines:
Initial Phase: Endoscopy at 3, 6, and 12 months after completion of EET.
Intermediate Phase: Following two consecutive endoscopies that are negative for neoplasia (from the initial phase), perform surveillance annually for 5 years.
Long-Term Phase: Following 5 years of annual negative endoscopies for neoplasia, surveillance should be performed every 2 years.